Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

BACKGROUND: The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central and Eastern Europe. The aim of this research was to provide a comprehensive description of country-specific health technology assessmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Malinowski, Krzysztof Piotr, Kawalec, Paweł, Trąbka, Wojciech, Sowada, Christoph, Petrova, Guenka, Manova, Manoela, Savova, Alexandra, Draganić, Pero, Slabý, Juraj, Männik, Agnes, Márky, Kristóf, Rugaja, Zinta, Gulbinovic, Jolanta, Tesar, Tomas, Paveliu, Marian Sorin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545889/
https://www.ncbi.nlm.nih.gov/pubmed/33032634
http://dx.doi.org/10.1186/s13023-020-01556-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545889/
https://www.ncbi.nlm.nih.gov/pubmed/33032634
http://dx.doi.org/10.1186/s13023-020-01556-9

Ejemplares similares